Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386217 · ClinicalTrials.gov registry record
Psychosocial Impact of Cancer-Related Female Infertility
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 239
- Enrollment target
NCT00386217: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00386217 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386217 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
The success of cancer treatment combined with the trend to delay childbearing is increasing the numbers of women survivors whose childbearing has been interrupted by cancer. For some, treatment has resulted in infertility. Others have been advised to delay pregnancy until a certain follow-up interval or have new fears that pregnancy could be a risk to maternal health. Not least is the concern that children born after a mother's cancer would face increased risks for birth defects or cancer. The specific aims of this project are as follows: 1. To measure the impact of cancer-related interruption of childbearing on women's long-term emotional well-being and health-related quality of life, over and above other demographic and cancer-related factors 2. To find out if becoming a biological or social mother after cancer treatment decreases the long-term psychosocial impact of interrupted childbearing compared to remaining childless 3. To refine the psychometric properties of questionnaires for female cancer survivors measuring Distress about Cancer-Related Childbearing Issues and Attitudes towards Parenthood after Cancer 4. To define targets for a future intervention to improve female survivors' knowledge about childbearing after cancer, decrease distress associated with interrupted childbearing, and promote peer support.
Interventions
- BEHAVIORAL Telephone Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2004-12 |
| Est. Completion | 2008-11 |
What the finished NCT00386217 record still lists
NCT00386217 is an observational study that tracks outcomes without assigning an intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Telephone Survey is the first listed.
NCT00386217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00386217 about?
NCT00386217 is a clinical study titled "Psychosocial Impact of Cancer-Related Female Infertility". The success of cancer treatment combined with the trend to delay childbearing is increasing the numbers of women survivors whose childbearing has been interrupted by cancer. For some, treatment has resulted in infertility. Others have been advised to delay pregnancy until a certain follow-up interva...
What is the current status of trial NCT00386217?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2004-12. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00386217?
The interventions under investigation include: Telephone Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00386217?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia